The DOI matches its Crossref record.
New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave
Abstract
Interstitial cystitis/bladder pain syndrome (IC/BPS), which is characterized by bladder pain and irritative voiding symptoms, is a frustrating disease without effective treatment. The cause is still largely not understood, although urothelium ischemia/hypoxia, apoptosis, denudation, and infiltration of inflammatory cells are common histopathological findings. The current uncertainty regarding the etiology and pathology of IC/BPS has a negative impact on its timely and successful treatment; therefore, the development of new treatment modalities is urgently needed. Herein, we present advances in our knowledge on this topic and review the potential application of regenerative medicine for the treatment of IC/BPS. This article provides information on the basic characteristics and clinical evidence of stem cells, platelet-rich plasma (PRP), and low-energy shock waves (LESWs) based on a literature review with a search strategy for articles related to IC/BPS, stem cells, PRP, and LESW published in MEDLINE and PubMed. Stem cells, PRP, and LESW, which modulate inflammatory processes and promote tissue repair, have been proven to improve bladder regeneration, relieve bladder pain, inhibit bladder inflammation, and increase bladder capacity in some preclinical studies. However, clinical studies are still in their infancy. Based on the mechanisms of action of stem cells, PRP, and LESW documented in many preclinical studies, the potential applications of regenerative medicine for the treatment of IC/BPS is an emerging frontier of interest. However, solid evidence from clinical studies remains to be obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A randomized comparative trial is still lacking [98].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [98]
In the citing paper
“Although BoNT-A, PRP, and LESWs have been shown to effectively reduce inflammation, improve urothelial regeneration, and improve IC symptoms in IC/BPS bladders, the relevant clinical trials are few.”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 77
- 10.1016/B978-0-323-02902-5.50048-4 · doi:10.1016/b978-0-323-02902-5.50048-4
- 10.5213/inj.1632712.356 · DOI · Paper page
- 10.1016/j.juro.2011.03.132 · DOI · Paper page
- 10.1016/j.juro.2012.08.088 · DOI · Paper page
- 10.1016/S0022-5347(05)64847-1 · DOI
- 10.1016/S0002-9343(03)00257-2 · doi:10.1016/s0002-9343(03)00257-2
- 10.1007/s00345-010-0536-4 · DOI
- 10.1002/nau.22515 · DOI
- 10.1016/j.juro.2008.06.035 · doi:10.1016/j.juro.2008.06.035
- 10.1016/j.eururo.2007.09.019 · DOI · Paper page
- 10.1016/j.eururo.2003.11.021 · DOI · Paper page
- 10.1016/j.urology.2005.04.011 · doi:10.1016/j.urology.2005.04.011
- Homma, 2020, Clinical guidelines for interstitial cystitis/bladder pain syndrome, 10.1111/iju.14234 · DOI · Paper page
- 10.1007/978-3-642-16499-6_10 · doi:10.1007/978-3-642-16499-6_10
- 10.1111/j.1464-410X.2010.09843.x · DOI · Paper page
- 10.1016/j.juro.2007.09.022 · DOI
- 10.1016/j.juro.2007.05.125 · DOI
- 10.1111/j.1464-410X.2007.06795.x · DOI
- Shie, 2012, Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome, 484.e7
- 10.1111/j.1464-410X.2008.08097.x · DOI
- 10.1016/S0022-5347(05)67873-1 · DOI
- 10.1097/01.ju.0000148361.82074.77 · doi:10.1097/01.ju.0000148361.82074.77
- 10.1097/01.ju.0000143192.68223.f7 · doi:10.1097/01.ju.0000143192.68223.f7
- 10.1016/j.urology.2006.08.1109 · DOI · Paper page
- 10.1016/j.urology.2011.06.014 · DOI
- Khullar, 2019, How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018, S71
- 10.1016/j.eururo.2007.01.029 · DOI
- Kim, 2016, Stem cell therapy for interstitial cystitis/bladder pain syndrome, 1
- 10.1038/s41585-019-0169-3 · DOI
- 10.1089/scd.2013.0277 · doi:10.1089/scd.2013.0277
- 10.1089/scd.2012.0176 · DOI · Paper page
- 10.4111/kju.2014.55.4.228 · DOI
- 10.1126/science.282.5391.1145 · DOI · Paper page
- 10.1007/s12015-017-9766-9 · DOI
- 10.1126/science.329.5996.1132 · doi:10.1126/science.329.5996.1132
- 10.1016/j.cell.2006.07.024 · DOI · Paper page
- 10.1016/j.cell.2007.11.019 · DOI · Paper page
- 10.5534/wjmh.2016.34.3.155 · DOI
- 10.1089/scd.2014.0459 · DOI
- 10.1016/j.bbrc.2017.11.072 · DOI
- 10.3727/096368915X689523 · DOI
- 10.1007/s00192-018-3592-8 · doi:10.1007/s00192-018-3592-8
- Li, 2017, Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model, 107
- 10.1038/s41598-017-09330-x · DOI
- 10.7150/thno.27559 · DOI
- 10.1016/j.mehy.2014.02.027 · DOI
- 10.1177/1756287219868590 · doi:10.1177/1756287219868590
- 10.1159/000477353 · DOI · Paper page
- 10.1136/bmjsem-2015-000060 · DOI · Paper page
- Ke, 2019, Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency, 135
- 10.1007/s12178-018-9520-1 · DOI
- 10.5213/inj.1632548.274 · doi:10.5213/inj.1632548.274
- 10.1111/luts.12212 · doi:10.1111/luts.12212
- 10.1002/nau.23898 · DOI · Paper page
- Wang, 2003, An overview of shock wave therapy in musculoskeletal disorders, 220
- 10.1016/j.ijsu.2015.11.030 · DOI · Paper page
- 10.1186/1749-799X-7-11 · DOI · Paper page
- 10.1136/bjsports-2012-091961 · doi:10.1136/bjsports-2012-091961
- 10.1302/0301-620X.86B2.14253 · doi:10.1302/0301-620x.86b2.14253
- 10.1155/2016/3850461 · doi:10.1155/2016/3850461
- 10.1016/S0140-6736(08)61793-6 · DOI · Paper page
- 10.1016/j.urology.2003.10.034 · doi:10.1016/j.urology.2003.10.034
- 10.1016/j.urology.2011.05.050 · DOI
- 10.1016/S0022-5347(17)53841-0 · DOI · Paper page
- Wang, 2003, An overview of shock wave therapy in musculoskeletal disorders, 220
- 10.1111/j.1582-4934.2011.01393.x · DOI
- 10.1016/j.juro.2011.12.117 · DOI · Paper page
- 10.2174/092986709788682119 · DOI · Paper page
- 10.1002/nau.23141 · doi:10.1002/nau.23141
- Chen, 2014, Extracorporeal shock wave therapy ameliorates cyclophosphamide-induced rat acute interstitial cystitis though inhibiting inflammation and oxidative stress-in vitro and in vivo experiment studies, 631
- 10.1074/jbc.M114.580936 · DOI · Paper page
- 10.1159/000358697 · DOI
- 10.1159/000493616 · DOI
- 10.1016/j.eururo.2009.03.043 · DOI · Paper page
- 10.1002/nau.24017 · doi:10.1002/nau.24017
- 10.1002/nau.24382 · DOI
- 10.1016/S0022-5347(01)69129-8 · DOI
Cited by
Yu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
Metadata
- Authors
- Lin, C.-C., Huang, Y.-C., Lee, W.-C., & Chuang, Y.-C.
- Venue
- International Neurourology Journal
- Publisher
- Korean Continence Society
- Published
- 2020-09-30
- Volume
- 24
- Issue
- 3
- Pages
- 211-221
- ISSN
- 2093-6931
- Cited by
- 41
- References
- 0
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Funders
- Kaohsiung Chang Gung Memorial Hospital (CMRPG8H0452, CRRPG8J0161E)
- National Science Council Taiwan (106-2314-B-182A-122-MY3)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave. https://app.cochat.ai/papers/10.5213/inj.2040104.052
- The paper
- Lin, C.-C., Huang, Y.-C., Lee, W.-C., & Chuang, Y.-C. (2020). New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave. International Neurourology Journal. https://doi.org/10.5213/inj.2040104.052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.